BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
CLBK
Columbia Financial, Inc.
CLBK has a slight edge over BAC overall on the model score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
CLBK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CLBK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CLBK.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over CLBK in the historical PE scenario, which offers more potential upside but is not a forecast.
CLBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $11.22 | — |
| Cheap | 24x | $5.10 | -55% |
| Fair | 33x | $6.85 | -39% |
| Current | 53x | $11.22 | — |
| Expensive | 95x | $19.98 | +78% |
Historical ranges are pointers, not guarantees.
CLBK's PE is in its expensive range at 53x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
CLBK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for CLBK, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over CLBK on earnings, with more consistent year-over-year improvement.
CLBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.70 | +233% |
| Q3 2026 | $0.21 | +200% |
| Q2 2026 | $0.26 | +767% |
| Q1 2026 | $0.25 | +$0.25 |
| Q4 2025 | $0.23 | +$0.28 |
| Q3 2025 | $0.07 | 0% |
| Q2 2025 | $0.03 | -63% |
| Q1 2025 | -$0.00 | -100% |
| Q4 2024 | -$0.05 | -131% |
CLBK's earnings per share have fallen from their peak: $0.21 over the past year, against $0.40 in late 2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over CLBK on profitability, with a higher operating margin.
CLBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $100.5M | +49% |
| Q2 2026 | $73.7M | +15% |
| Q1 2026 | $67.1M | +14% |
| Q4 2025 | $68.8M | +203% |
| Q3 2025 | $67.3M | +24% |
| Q2 2025 | $63.9M | +20% |
| Q1 2025 | $58.8M | +18% |
| Q4 2024 | $22.7M | -60% |
CLBK's revenue has grown year over year for seven quarters in a row: $100M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.1% | -28 points |
| Q2 2026 | 27% | +1.3 points |
| Q1 2026 | 28% | +7.4 points |
| Q4 2025 | 29% | +146 points |
| Q3 2025 | 29% | +16 points |
| Q2 2025 | 26% | +17 points |
| Q1 2025 | 20% | +23 points |
| Q4 2024 | -118% | -131 points |
CLBK's operating margin was 1.1% last quarter, down 28 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with CLBK at up 48%.
CLBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $47.5M | +69% |
| Q1 2026 | $1.3M | +$5.8M |
| Q4 2025 | $22M | -19% |
| Q3 2025 | $28.1M | +$59.2M |
| Q2 2025 | $12.9M | -25% |
| Q1 2025 | -$4.5M | -136% |
| Q4 2024 | $27.3M | +$62.1M |
| Q3 2024 | -$31.1M | -176% |
CLBK's free cash flow was $99M over the past year, more than ten times what it generated the year before. Free cash flow isn't a meaningful measure for financial services companies like CLBK.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over CLBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
CLBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +12% | +27.4M shares |
| 1 year | +12% | +27.2M shares |
| 3 years | +12% | +27M shares |
| 5 years | +11% | +25.1M shares |
| Available history | +4% | +9.8M shares |
CLBK has 252M diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $10.5M |
| Q3 2025 | $2.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $4.2M |
| Q1 2024 | $1.7M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
CLBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 11.3x | High |
| Q4 2025 | 10.7x | High |
| Q3 2025 | 31.4x | High |
| Q2 2025 | 52.4x | High |
| Q1 2025 | 108.8x | High |
| Q3 2024 | 39.8x | High |
| Q2 2024 | 39.1x | High |
| Q1 2024 | 38.4x | High |
CLBK's net debt is about 11 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CLBK.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
CLBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.2 | Neutral |
| Stochastic | 40.9 | Neutral |
CLBK's weekly RSI is 63 (neutral) and its Stochastic is 41 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over CLBK on valuation relative to its sector.
CLBK PE vs Financial Services Sector
| Metric | CLBK | Sector median | Relative |
|---|---|---|---|
| PE | 53x | 13x | 309% above |
| PE % | 79 | 63 | 16 pts above |
CLBK is trading at 53x earnings, a 309% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
CLBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.1 | 1.5% above |
| 20 week MA | $11.0 | 1.6% above |
| 50 week MA | $9.34 | 20% above |
| 100 week MA | $8.06 | 39% above |
| 200 week MA | $7.97 | 41% above |
CLBK has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
CLBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.82 | $6.97 | -11% |
| 2021 | $6.97 | $9.40 | +35% |
| 2022 | $9.40 | $9.76 | +3.8% |
| 2023 | $9.76 | $8.76 | -10% |
| 2024 | $8.76 | $7.19 | -18% |
| 2025 | $7.19 | $7.33 | +1.9% |
| 2026 YTD | $7.33 | $11.2 | +53% |
CLBK has the edge over BAC on returns for 2026, with the stronger performance.